Abbott in development agreement with Axis:
This article was originally published in Clinica
Axis Biochemicals (Norway) is to develop a homocysteine kit for use on Abbott's IMx immunoassay system. The marker is used for cardiovascular risk and nutritional assessment. Standard measurement methods mainly use chromatography and are not generally automated. Abbott will license an antibody clone of homocysteine to Axis and will receive royalty payments. Axis will have the rights to sell any resulting products to existing Abbott customers but Abbott has an option to distribute the assay at a later date.